Biofarmacevtsko inženirstvo

The BioPharmaceutical Engineering study program is an interdisciplinary, three-year professional higher education program offered by four faculties of the University of Ljubljana (FFA, FKKT, BF, FRI). It is designed to educate professionals for the development and production of biological medicines. The program combines fundamental knowledge in natural sciences, biotechnology, pharmacy, engineering, and information technology with applied content and spans three years, with progressive horizontal and vertical knowledge advancement. Special emphasis is placed on linking theory with practice, as reflected in laboratory exercises, project work, practical training, and research collaborations with industry. The program develops competencies for independent work, critical thinking, and teamwork. The program comprises 180 ECTS credits with 40 available places. Teaching includes lectures, seminars, laboratory exercises, and practical work. The faculties provide adequate staff and facilities, as well as modern research equipment, enabling direct exposure to biopharmaceutical production processes. The program responds to the needs of Slovenia’s rapidly growing biopharmaceutical industry, where significant investments and demand for new professionals are expected. Students gain extensive practical experience through the Work in Practice course and guest lectures from industry experts. Course leaders are active members of professional societies and collaborate with national and international research institutions. The program is supported by multiple cooperation agreements with key partners. In the first year, students acquire fundamental natural science and pharmaceutical knowledge; in the second year, they focus on analytical, molecular-biological, and bioengineering topics with an emphasis on industrial production; the third year covers regulatory requirements, clinical trials, and quality assurance. The program also enables international mobility and faculty exchange. Admission is open to candidates with a general or vocational matura or a four-year secondary education program, along with proof of Slovenian language proficiency at B2 level. Progression depends on completing the required ECTS credits (60 for the second year, 55 for the third year), and re-enrollment is possible with a minimum of 30 ECTS credits. Previously acquired knowledge can be recognized upon request to the relevant Study Commission. Assessment is based on exams, colloquia, and independent work, with a passing threshold of 55%. To complete the program, students must fulfill all requirements (180 ECTS credits), including a final report on their practical training. Graduates are awarded the professional title Graduate BioPharmaceutical Engineer (VS). Transfers from related first-cycle Bologna programs are possible, with recognition of completed obligations and determination of any additional requirements. The program provides interdisciplinary education, practical competencies, and the use of modern technology, preparing graduates for work across various segments of the biopharmaceutical industry.